Verseau Therapeutics is a multifaceted platform company with a broad focus on macrophages in human disease. The platform is built around a discovery engine combining computational approaches with original validation assays based on human samples. The Verseau pipeline will combine monoclonal antibodies, small molecules, and novel therapeutic modalities using nucleic-acid-carrying lipid nanoparticles. The company holds IP from MIT laboratories of Robert Langer and Daniel Anderson and has internal know-how around methods of delivery to macrophages. The early application of our platform is in cancer. The goal is to complement current approved therapies based on T cell checkpoint inhibitors and to broaden immune therapy utility by activating immune response to tumors with no prior T cell reactivity. Our goal is to build a leading biopharmaceutical brand with focus on macrophage-based therapies in a broad spectrum of disease indications.

To inquire about current openings or to apply to any of the positions below please contact

Current Openings

Verseau Therapeutics is an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, disability status, protected veteran status, gender identity, sexual orientation, pregnancy and pregnancy-related conditions, or any other characteristic protected by law.